Fermi Inc. — Investor Relations & Filings
Filings indexed
97
across all filing types
Latest filing
2026-05-22
Proxy Solicitation & In…
Country
US
United States of America
Listing
US
FRMI
Fermi Inc. is a company developing next-generation electric grids and large-scale artificial intelligence (AI) data center campuses. The company's primary project is an advanced energy and AI campus designed to deliver 11 gigawatts of highly redundant power. This infrastructure utilizes a hybrid energy model that integrates nuclear, natural gas, and solar power generation. Fermi's business model involves leasing data center space and providing dedicated, on-site power to clients with significant computational requirements, such as AI laboratories and cloud providers. By co-locating power generation with data centers, the company aims to directly address the substantial energy demands of the AI sector.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| SOLICITING MATERIAL PURSUANT TO 240.14A-12A | 2026-05-22 | English | |
| SOLICITING MATERIAL PURSUANT TO 240.14A-12A | 2026-05-20 | English | |
| SOLICITING MATERIAL PURSUANT TO 240.14A-12A | 2026-05-20 | English | |
| SOLICITING MATERIAL PURSUANT TO 240.14A-12A | 2026-05-19 | English | |
| SOLICITING MATERIAL UNDER 240.14A-12 | 2026-05-19 | English | |
| SOLICITING MATERIAL PURSUANT TO SECTION 240.14A-12 | 2026-05-18 | English |
Browse filings by year
2 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46818097 | SOLICITING MATERIAL PURSUANT TO 240.14A-12A | 2026-05-22 | English | ||
| 46691536 | SOLICITING MATERIAL PURSUANT TO 240.14A-12A | 2026-05-20 | English | ||
| 46601862 | SOLICITING MATERIAL PURSUANT TO 240.14A-12A | 2026-05-20 | English | ||
| 46555844 | SOLICITING MATERIAL PURSUANT TO 240.14A-12A | 2026-05-19 | English | ||
| 46555841 | SOLICITING MATERIAL UNDER 240.14A-12 | 2026-05-19 | English | ||
| 46471531 | SOLICITING MATERIAL PURSUANT TO SECTION 240.14A-12 | 2026-05-18 | English | ||
| 46385489 | Preliminary Consent Revocation Statement | 2026-05-18 | English | ||
| 46359945 | 1st Quarter Results | 2026-05-15 | English | ||
| 46351867 | FRMI Q1 2026 FORM 10-Q | 2026-05-14 | English | ||
| 46302389 | SOLICITING MATERIAL PURSUANT TO 240.14A-12A | 2026-05-14 | English | ||
| 45974874 | 1st Quarter Results | 2026-05-14 | English | ||
| 45865322 | Form 8-K | 2026-05-14 | English | ||
| 45955005 | FRMI FORM 8-K FOR Q1 2026 ER | 2026-05-14 | English | ||
| 45954983 | CURRENT REPORT | 2026-05-14 | English | ||
| 44893805 | First Quarter 2026 Earnings Release & Call Date | 2026-05-11 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
THERACRYF PLC
Develops sulforaphane-based medicines for behavioural brain…
|
TCF | GB | Professional, scientific and te… |
|
Theriva Biologics, Inc.
Clinical-stage company developing systemically delivered on…
|
TOVX | US | Professional, scientific and te… |
|
Thirdeye Systems Ltd.
Develops AI object recognition algorithms and hardware for …
|
THES | IL | Professional, scientific and te… |
|
TISSUE REPAIR LTD
Clinical-stage developer of advanced wound healing and skin…
|
TRP | AU | Professional, scientific and te… |
|
TiumBio Co., Ltd.
Biopharmaceutical firm developing therapeutics for rare and…
|
321550 | KR | Professional, scientific and te… |
|
Tiziana Life Sciences Ltd
Develops immunotherapies for neurodegenerative and neuroinf…
|
TLSA | BM | Professional, scientific and te… |
|
Tm Bioscience Corporation
Molecular diagnostics company commercializing proprietary D…
|
TMC | CA | Professional, scientific and te… |
|
Toleranzia AB
A dissolved biotech company that developed therapies for au…
|
TOL | SE | Professional, scientific and te… |
|
ToolGen Incorporated
Biotechnology company developing genome editing for therape…
|
199800 | KR | Professional, scientific and te… |
|
Transcode Therapeutics, Inc.
Clinical-stage oncology company developing RNA-based therap…
|
RNAZ | US | Professional, scientific and te… |
Fermi Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/17756/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=17756 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=17756 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=17756 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 17756}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Fermi Inc. (id: 17756)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.